Kirk Midkiff

659 total citations
10 papers, 462 citations indexed

About

Kirk Midkiff is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Rheumatology. According to data from OpenAlex, Kirk Midkiff has authored 10 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 3 papers in Rheumatology. Recurrent topics in Kirk Midkiff's work include Sarcoma Diagnosis and Treatment (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Bone health and treatments (2 papers). Kirk Midkiff is often cited by papers focused on Sarcoma Diagnosis and Treatment (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Bone health and treatments (2 papers). Kirk Midkiff collaborates with scholars based in United States and United Kingdom. Kirk Midkiff's co-authors include Alicia Gilsenan, Elizabeth Andrews, Beth Sherrill, Yun Wu, Daniel N. Masica, Lisa J. McQuay, David Harris, Cristina Varas‐Lorenzo, Catherine B. Johannes and Daniel Fife and has published in prestigious journals such as The Journal of Urology, Journal of Bone and Mineral Research and Osteoporosis International.

In The Last Decade

Kirk Midkiff

10 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kirk Midkiff United States 7 195 189 144 91 54 10 462
Judith Clearwater New Zealand 8 103 0.5× 283 1.5× 88 0.6× 81 0.9× 47 0.9× 9 635
Diala El‐Maouche United States 14 188 1.0× 48 0.3× 224 1.6× 52 0.6× 134 2.5× 25 635
Jun‐Yen Yeh United States 7 125 0.6× 100 0.5× 113 0.8× 69 0.8× 28 0.5× 8 452
Palak Choksi United States 10 117 0.6× 146 0.8× 66 0.5× 113 1.2× 35 0.6× 23 504
Oswaldo L. Bracco United States 8 119 0.6× 81 0.4× 148 1.0× 131 1.4× 45 0.8× 15 869
Di Valentine United States 4 181 0.9× 307 1.6× 97 0.7× 130 1.4× 20 0.4× 4 427
Lorenzo Sandini Finland 15 109 0.6× 379 2.0× 66 0.5× 119 1.3× 23 0.4× 16 662
Z. Chen United States 7 457 2.3× 241 1.3× 205 1.4× 106 1.2× 50 0.9× 8 796
J Lachmanová Czechia 13 79 0.4× 43 0.2× 82 0.6× 50 0.5× 81 1.5× 31 417
Jean M. Kaufman Belgium 8 80 0.4× 93 0.5× 75 0.5× 124 1.4× 70 1.3× 10 563

Countries citing papers authored by Kirk Midkiff

Since Specialization
Citations

This map shows the geographic impact of Kirk Midkiff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirk Midkiff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirk Midkiff more than expected).

Fields of papers citing papers by Kirk Midkiff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirk Midkiff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirk Midkiff. The network helps show where Kirk Midkiff may publish in the future.

Co-authorship network of co-authors of Kirk Midkiff

This figure shows the co-authorship network connecting the top 25 collaborators of Kirk Midkiff. A scholar is included among the top collaborators of Kirk Midkiff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirk Midkiff. Kirk Midkiff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Gilsenan, Alicia, et al.. (2020). Teriparatide Did Not Increase Adult Osteosarcoma Incidence in a 15-Year US Postmarketing Surveillance Study. Journal of Bone and Mineral Research. 36(2). 244–251. 55 indexed citations
2.
Gilsenan, Alicia, David Harris, Maria Reynolds, et al.. (2020). Long-term cancer surveillance: results from the Forteo Patient Registry Surveillance Study. Osteoporosis International. 32(4). 645–651. 15 indexed citations
3.
Gilsenan, Alicia, Kirk Midkiff, David Harris, et al.. (2020). Assessing the incidence of osteosarcoma among teriparatide users based on Medicare Part D and US State Cancer Registry Data. Pharmacoepidemiology and Drug Safety. 29(12). 1616–1626. 12 indexed citations
4.
Gilsenan, Alicia, et al.. (2018). The Forteo Patient Registry linkage to multiple state cancer registries: study design and results from the first 8 years. Osteoporosis International. 29(10). 2335–2343. 44 indexed citations
5.
Midkiff, Kirk, Elizabeth Andrews, Alicia Gilsenan, et al.. (2016). The experience of accommodating privacy restrictions during implementation of a large‐scale surveillance study of an osteoporosis medication. Pharmacoepidemiology and Drug Safety. 25(8). 960–968. 6 indexed citations
6.
Johannes, Catherine B., Lisa J. McQuay, Kirk Midkiff, et al.. (2016). The feasibility of using multiple databases to study rare outcomes: the potential effect of long-acting beta agonists with inhaled corticosteroid therapy on asthma mortality. Pharmacoepidemiology and Drug Safety. 26(4). 446–458. 1 indexed citations
7.
Andrews, Elizabeth, Alicia Gilsenan, Kirk Midkiff, et al.. (2012). The US postmarketing surveillance study of adult osteosarcoma and teriparatide: Study design and findings from the first 7 years. Journal of Bone and Mineral Research. 27(12). 2429–2437. 194 indexed citations
8.
Johannes, Catherine B., Cristina Varas‐Lorenzo, Lisa J. McQuay, Kirk Midkiff, & Daniel Fife. (2010). Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case‐control study. Pharmacoepidemiology and Drug Safety. 19(9). 881–888. 101 indexed citations
9.
Naslund, Michael J., et al.. (2007). Prevalence of lower urinary tract symptoms and prostate enlargement in the primary care setting. International Journal of Clinical Practice. 61(9). 1437–1445. 33 indexed citations
10.
Gilsenan, Alicia, et al.. (2007). 1499: The Prevalence of LUTS and Prostate Enlargement in the Primary Care Setting. The Journal of Urology. 177(4S). 494–495. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026